344 related articles for article (PubMed ID: 32778730)
21. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.
Kim HY; Chang YJ; Subramanian S; Lee HH; Albacker LA; Matangkasombut P; Savage PB; McKenzie AN; Smith DE; Rottman JB; DeKruyff RH; Umetsu DT
J Allergy Clin Immunol; 2012 Jan; 129(1):216-27.e1-6. PubMed ID: 22119406
[TBL] [Abstract][Full Text] [Related]
22. IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates cellular metabolism, and ameliorates airway hyperreactivity.
Howard E; Lewis G; Galle-Treger L; Hurrell BP; Helou DG; Shafiei-Jahani P; Painter JD; Muench GA; Soroosh P; Akbari O
J Allergy Clin Immunol; 2021 Apr; 147(4):1281-1295.e5. PubMed ID: 32905799
[TBL] [Abstract][Full Text] [Related]
23. Autophagy is critical for group 2 innate lymphoid cell metabolic homeostasis and effector function.
Galle-Treger L; Hurrell BP; Lewis G; Howard E; Jahani PS; Banie H; Razani B; Soroosh P; Akbari O
J Allergy Clin Immunol; 2020 Feb; 145(2):502-517.e5. PubMed ID: 31738991
[TBL] [Abstract][Full Text] [Related]
24. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction.
Barlow JL; Peel S; Fox J; Panova V; Hardman CS; Camelo A; Bucks C; Wu X; Kane CM; Neill DR; Flynn RJ; Sayers I; Hall IP; McKenzie AN
J Allergy Clin Immunol; 2013 Oct; 132(4):933-41. PubMed ID: 23810766
[TBL] [Abstract][Full Text] [Related]
25. Activated plasmacytoid dendritic cells regulate type 2 innate lymphoid cell-mediated airway hyperreactivity.
Maazi H; Banie H; Aleman Muench GR; Patel N; Wang B; Sankaranarayanan I; Bhargava V; Sato T; Lewis G; Cesaroni M; Karras J; Das A; Soroosh P; Akbari O
J Allergy Clin Immunol; 2018 Mar; 141(3):893-905.e6. PubMed ID: 28579374
[TBL] [Abstract][Full Text] [Related]
26. Piezo1 channels restrain ILC2s and regulate the development of airway hyperreactivity.
Hurrell BP; Shen S; Li X; Sakano Y; Kazemi MH; Quach C; Shafiei-Jahani P; Sakano K; Ghiasi H; Akbari O
J Exp Med; 2024 May; 221(5):. PubMed ID: 38530239
[TBL] [Abstract][Full Text] [Related]
27. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33.
Christianson CA; Goplen NP; Zafar I; Irvin C; Good JT; Rollins DR; Gorentla B; Liu W; Gorska MM; Chu H; Martin RJ; Alam R
J Allergy Clin Immunol; 2015 Jul; 136(1):59-68.e14. PubMed ID: 25617223
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
29. T cells are necessary for ILC2 activation in house dust mite-induced allergic airway inflammation in mice.
Li BW; de Bruijn MJ; Tindemans I; Lukkes M; KleinJan A; Hoogsteden HC; Hendriks RW
Eur J Immunol; 2016 Jun; 46(6):1392-403. PubMed ID: 27062360
[TBL] [Abstract][Full Text] [Related]
30. TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.
Okuzumi S; Miyata J; Kabata H; Mochimaru T; Kagawa S; Masaki K; Irie M; Morita H; Fukunaga K
Am J Respir Cell Mol Biol; 2021 Sep; 65(3):309-318. PubMed ID: 34003734
[TBL] [Abstract][Full Text] [Related]
31. Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice.
Drake LY; Iijima K; Kita H
Allergy; 2014 Oct; 69(10):1300-7. PubMed ID: 24939388
[TBL] [Abstract][Full Text] [Related]
32. SLAM-family receptors promote resolution of ILC2-mediated inflammation.
Wang Y; Quan Y; He J; Chen S; Dong Z
Nat Commun; 2024 Jun; 15(1):5056. PubMed ID: 38871792
[TBL] [Abstract][Full Text] [Related]
33. Tilianin attenuates HDM-induced allergic asthma by suppressing Th2-immune responses via downregulation of IRF4 in dendritic cells.
Park SJ; Lee K; Kang MA; Kim TH; Jang HJ; Ryu HW; Oh SR; Lee HJ
Phytomedicine; 2021 Jan; 80():153392. PubMed ID: 33113503
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
[TBL] [Abstract][Full Text] [Related]
35. Human PD-1 agonist treatment alleviates neutrophilic asthma by reprogramming T cells.
Helou DG; Quach C; Fung M; Painter JD; Hurrell BP; Eddie Loh YH; Howard E; Shafiei-Jahani P; Soroosh P; Sharpe AH; Akbari O
J Allergy Clin Immunol; 2023 Feb; 151(2):526-538.e8. PubMed ID: 35963455
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary IL-33 orchestrates innate immune cells to mediate respiratory syncytial virus-evoked airway hyperreactivity and eosinophilia.
Wu YH; Lai AC; Chi PY; Thio CL; Chen WY; Tsai CH; Lee YL; Lukacs NW; Chang YJ
Allergy; 2020 Apr; 75(4):818-830. PubMed ID: 31622507
[TBL] [Abstract][Full Text] [Related]
37. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
38. Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.
van Rijt L; von Richthofen H; van Ree R
Semin Immunopathol; 2016 Jul; 38(4):483-96. PubMed ID: 26965110
[TBL] [Abstract][Full Text] [Related]
39. Group 2 innate lymphoid cells (ILC2s): The spotlight in asthma pathogenesis and lung tissue injury.
Sadik S; Lu Y; Zhu S; Cai J; Mi LL
Allergol Immunopathol (Madr); 2021; 49(2):208-216. PubMed ID: 33641310
[TBL] [Abstract][Full Text] [Related]
40. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
